Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Adjunctive perampanel for primary generalized tonic-clonic seizures
2011-000265-12Phase 3Completed
- Sponsor
- Eisai Co., Ltd.
- Start
- Jun 2011
- Modality
- Classical Binding Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, double-blind trial of perampanel in generalized tonic-clonic seizure (GTCS) (3 arms), sponsored by Eisai Co., Ltd. Primary endpoint: Percent change in primary generalized tonic-clonic seizure frequency. Started Jun 2011; status: completed.
02
Drugs
perampanel
03
Conditions
generalized tonic-clonic seizure (GTCS)
Beyond the preview
Go deeper on 2011-000265-12.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2011-000265-12.